Correction to: Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Correction to: Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment

Authors:	D. Gouty C. C. Cai X. Y. Cai A. Kasinath V. Kumar S. Alvandkouhi J. Yang S. Pederson B. Babbitt D. Peritt A. Rudy V. Koppenburg A. Dasilva M. Ullmann S. Liu C. Satterwhite

Affiliation:	1.BioAgilytix Labs,Durham,USA;2.Pfizer Inc,Groton,USA;3.WuXi AppTec Co. Ltd,Shanghai,China;4.Syngene International Ltd,Bangalore,India;5.Biologics, Dr. Reddy’s Laboratories Ltd.,Hyderabad,India;6.BioAgilytix Labs,Durham,USA;7.Genentech, Inc, South San Francisco,California,USA;8.Alder Biopharmaceuticals Inc.,Bothell,USA;9.PAREXEL International Corp,Waltham,USA;10.Pfizer Inc,Cambridge,USA;11.Sandoz Biopharmaceuticals/Hexal AG,Holzkirchen,Germany;12.Sandoz Biopharmaceuticals/Hexal AG,Holzkirchen,Germany;13.Sandoz Biopharmaceuticals/Hexal AG,Holzkirchen,Germany;14.Merck KGA,Geneva,Switzerland;15.Apobiologix,Toronto,Canada;16.Charles River Laboratory,Reno,USA

Abstract:

Keywords:
本文献已被 SpringerLink 等数据库收录！